Showing results (101-110 of 157) with videos related to
Sort By:
Pageof 16
Journal of the European Academy of Dermatology and Venereology : JEADV|January 11, 2020
Efficacy of tildrakizumab by patient demographic and disease characteristics across a phase 2b and 2 phase 3 trials in patients with moderate-to-severe chronic plaque psoriasisY Poulin, M Ramon, L Rosoph, et al.Journal of Drugs in Dermatology : JDD|December 31, 2008
Etanercept in the treatment of palmoplantar pustulosisR Bissonnette, Y Poulin, C Bolduc, et al.Dermatology (Basel, Switzerland)|October 6, 2005
Alefacept in the treatment of psoriasis in patients for whom conventional therapies are inadequateP van de Kerkhof, C E M Griffiths, E Christophers, et al.The British Journal of Dermatology|November 12, 2009
Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trialM Lebwohl, K Papp, C Han, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|June 7, 2017
Early relapse of psoriasis after stopping brodalumab: a retrospective cohort study in 77 patientsM Masson Regnault, M-P Konstantinou, A Khemis, et al.The British Journal of Dermatology|October 15, 2013
Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1P Rich, M Bourcier, H Sofen, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 5, 2011
Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinicJ Barker, E J Horn, M Lebwohl, et al.Journal of the American Academy of Dermatology|September 17, 1998
Cyclosporine consensus conference: with emphasis on the treatment of psoriasisM Lebwohl, C Ellis, A Gottlieb, et al.The British Journal of Dermatology|December 21, 2011
Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trialR Bissonnette, Y Poulin, Y Zhou, et al.Allergy|January 27, 2006
Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trialR Kaufmann, T Bieber, A L Helgesen, et al.Pageof 16